NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX)

CUSIP: 64125C109

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
99,963,154
Total 13F shares
93,218,731
Share change
+830,721
Total reported value
$12,853,312,563
Put/Call ratio
68%
Price per share
$137.92
Number of holders
580
Value change
+$116,424,918
Number of buys
305
Number of sells
256

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q1 2024

As of 31 Mar 2024, NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by 580 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,218,731 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, and JANUS HENDERSON GROUP PLC. This page lists 581 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.